Functional selectivity and classical concepts of quantitative pharmacology
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Citation
MLA
Urban, Jonathan D, et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology. 2007. https://doi.org/10.17615/38rs-3c95APA
Urban, J., Clarke, W., Von Zastrow, M., Nichols, D., Kobilka, B., Weinstein, H., Javitch, J., Roth, B., Christopoulos, A., Sexton, P., Miller, K., Spedding, M., & Mailman, R. (2007). Functional selectivity and classical concepts of quantitative pharmacology. https://doi.org/10.17615/38rs-3c95Chicago
Urban, Jonathan D., William P Clarke, Mark Von Zastrow, David E Nichols, Brian Kobilka, Harel Weinstein, Jonathan A Javitch et al. 2007. Functional Selectivity and Classical Concepts of Quantitative Pharmacology. https://doi.org/10.17615/38rs-3c95- Creator
-
Urban, Jonathan D.
- Affiliation: School of Medicine, Curriculum in Toxicology
-
Clarke, William P.
- Other Affiliation: Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX
-
von Zastrow, Mark
- Other Affiliation: Departments of Psychiatry and Cellular and Molecular Pharmacology, University of California, San Francisco, CA
-
Nichols, David E.
- Other Affiliation: Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue University, West Lafayette, IN
-
Kobilka, Brian
- Other Affiliation: Department of Molecular and Cellular Physiology, Stanford University, Palo Alto, CA
-
Weinstein, Harel
- Other Affiliation: Department of Physiology and Biophysics, and Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, NY
-
Javitch, Jonathan A.
- Other Affiliation: Center for Molecular Recognition, and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY
-
Roth, Bryan
- ORCID: https://orcid.org/0000-0002-0561-6529
- Affiliation: Eshelman School of Pharmacy, Division of Chemical Biology and Medicinal Chemistry, School of Medicine, Department of Psychiatry
-
Christopoulos, Arthur
- Other Affiliation: Department of Pharmacology, Monash University, Clayton, Victoria, Australia
-
Sexton, Patrick M.
- Other Affiliation: Department of Pharmacology, Monash University, Clayton, Victoria, Australia
-
Miller, Keith J.
- Other Affiliation: Obesity Department, Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ
-
Spedding, Michael
- Other Affiliation: Institute de Recherches Servier, Suresnes, France
-
Mailman, Richard B.
- Affiliation: School of Medicine, Curriculum in Toxicology, Department of Psychiatry
- Abstract
- The concept of intrinsic efficacy has been enshrined in pharmacology for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy. Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism. At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor. Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems. A variety of mechanisms may influence this apparently ubiquitous phenomenon. It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the β2-adrenergic receptor. Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers. Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism). Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action. It also may be timely to revise classic concepts in quantitative pharmacology and relevant pharmacological conventions to incorporate these new concepts.
- Date of publication
- 2007
- DOI
- Identifier
- 2-s2.0-33845903110
- https://doi.org/10.1124/jpet.106.104463
- Related resource URL
- Resource type
- Journal Item
- Rights statement
- In Copyright
- Journal title
- Journal of Pharmacology and Experimental Therapeutics
- Journal volume
- 320
- Journal issue
- 1
- Page start
- 1
- Page end
- 13
- Language
- English
- Version
- Postprint
- ISSN
- 0022-3565
Relations
- Parents:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
|
Functional Selectivity and Classical Concepts of Quantitative Pharmacology.pdf | 2019-05-03 | Public | Download |